NCT00085150View on ClinicalTrials.gov

LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2004

Conditions
LeukemiaLymphoma
Interventions
BIOLOGICAL

LMB-2 immunotoxin

Trial Locations (5)

30322

Winship Cancer Institute of Emory University, Atlanta

38105

St. Jude Children's Research Hospital, Memphis

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

97239-3098

Doernbecher Children's Hospital at Oregon Health & Science University, Portland

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00085150 - LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma | Biotech Hunter | Biotech Hunter